What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review

被引：10

作者：

Giaj-Levra, Niccolo ^{[1
]}

Ricchetti, Francesco ^{[1
]}

Alongi, Filippo ^{[1
]}

机构：

[1] Sacro Cuore Don Calabria Hosp, Dept Radiat Oncol, Negrar Verona, Italy

来源：

CANCER INVESTIGATION | 2016年 / 34卷 / 02期

关键词：

Non small cell lung cancer; Dose escalation; Locally advanced; New technology; Altered fractionation; Radiotherapy; THERAPY-ONCOLOGY-GROUP; PREDICTING RADIATION PNEUMONITIS; PHASE-III TRIAL; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; ISOTOXIC ACCELERATED RADIOTHERAPY; CONCURRENT CHEMORADIATION THERAPY; POSITRON-EMISSION-TOMOGRAPHY; LONG-TERM SURVIVAL; DOSE-ESCALATION; HYPOFRACTIONATED RADIOTHERAPY;

D O I：

10.3109/07357907.2015.1114121

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Radiotherapy treatment continues to have a relevant impact in the treatment of nonsmall cell cancer (NSCLC). Use of concurrent chemotherapy and radiotherapy is considered the gold standard in the treatment of locally advanced NSCLC but clinical outcomes are not satisfactory. Introduction of new radiotherapy technology and chemotherapy regimens are under investigation in this setting with the goal to improve unsatisfactory results. We report how radiotherapy is changing in the treatment of locally advanced NSCLC.

引用

页码：80 / 93

页数：14

共 50 条

[21] Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives
Antoni, Delphine
Mornex, Francoise
[J]. CURRENT OPINION IN ONCOLOGY, 2016, 28 (02) : 104 - 109
[22] Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers
Shaikh, Arif Y.
Haraf, Daniel J.
Salama, Joseph K.
Salgia, Ravi
Hoffman, Philip C.
Ferguson, Mark K.
Connell, Philip P.
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 258 - 263
[23] Prospective trial of combined hyperfractionated radiotherapy and bronchial arterial infusion of chemotherapy for locally advanced nonsmall cell lung cancer
Wang, GM
Song, MF
Xu, HY
Fang, Y
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (02): : 309 - 313
[24] Stereotactic radiotherapy for nonsmall cell lung cancer
Ball, David
[J]. CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (04) : 297 - 302
[25] THE CLINICOPATHOLOGICAL BEHAVIOR AND PATTERN OF TREATMENT OF INOPERABLE ADVANCED NONSMALL CELL LUNG CANCER PATIENTS
Kaur, P.
Chauhan, A.
Bharti, M. K.
Singh, G.
Sabharwal, R.
Sabharwal, M.
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (03): : 698 - 705
[26] Concomitant boost (CB) thoracic radiotherapy (TRT) in the treatment of locally advanced nonsmall cell lung cancer (NSCLC): the San Antonio Cancer Institute pilot experience
Lin, B
Eng, TY
Thomas, CR
[J]. LUNG CANCER, 2004, 46 : S47 - S48
[27] COMBINED-MODALITY TREATMENT FOR LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER - WHICH CONTROL ARM
JOHNSON, DH
[J]. LUNG CANCER, 1994, 10 : S231 - S238
[28] SURGICAL APPROACHES TO LOCALLY ADVANCED POTENTIALLY RESECTABLE NONSMALL CELL LUNG-CANCER
ROTH, JA
[J]. LUNG CANCER, 1994, 11 : S25 - S30
[29] CARBOPLATIN IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - A REVIEW
COMIS, RL
[J]. ONCOLOGY, 1993, 50 : 37 - 41
[30] Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Nonsmall Cell Lung Cancer
Hasturk, Serap
Hatabay, Nilgun
Ece, Ferah
Karatasli, Meltem
Hanta, Ismail
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 280 - 285

← 1 2 3 4 5 →